DHTI (Dalrada Technology Group) Cyclically Adjusted PS Ratio: 0.00 (As of Jun. 24, 2026)


What is Dalrada Technology Group Cyclically Adjusted PS Ratio?

Dalrada Technology Group DHTI +50.96% Cyclically Adjusted PS Ratio is 0.00 as of Jun. 24, 2026. The stock has 8 warning signs investors should review. Among 358 Healthcare Providers & Services companies, Dalrada Technology Group ranks worse than 279329.33% on this metric.

As of today (2026-06-24), Dalrada Technology Group's current share price is $0.0237. Dalrada Technology Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $8.63. Dalrada Technology Group's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for Dalrada Technology Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

During the past years, Dalrada Technology Group's highest Cyclically Adjusted PS Ratio was 0.03. The lowest was 0.01. And the median was 0.01.

DHTI's Cyclically Adjusted PS Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.16
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dalrada Technology Group's adjusted revenue per share data for the three months ended in Mar. 2026 was $0.024. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $8.63 for the trailing ten years ended in Mar. 2026.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dalrada Technology Group  (OTCPK:DHTI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Dalrada Technology Group Cyclically Adjusted PS Ratio Related Terms


Dalrada Technology Group Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Dalrada Technology Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dalrada Technology Group Cyclically Adjusted PS Ratio Chart

Dalrada Technology Group Annual Data
Trend Jun05 Jun06 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.01 0.01 0.02 0.00

Dalrada Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DHTI vs PMHS, RDGT, BLMH: Cyclically Adjusted PS Ratio Comparison

For the Pharmaceutical Retailers subindustry, Dalrada Technology Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dalrada Technology Group Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dalrada Technology Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dalrada Technology Group's Cyclically Adjusted PS Ratio falls into.



Dalrada Technology Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Dalrada Technology Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0237/8.63
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dalrada Technology Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Dalrada Technology Group's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.024/330.2130*330.2130
=0.024

Current CPI (Mar. 2026) = 330.2130.

Dalrada Technology Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200506 1.420 194.500 2.411
200509 3.202 198.800 5.319
200512 4.621 196.800 7.754
200603 0.224 199.800 0.370
200606 3.524 202.900 5.735
200609 7.515 202.900 12.230
200612 11.981 201.800 19.605
200703 8.925 205.352 14.352
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 0.000 254.202 0.000
201906 0.000 256.143 0.000
201909 0.000 256.759 0.000
201912 0.000 256.974 0.000
202003 0.006 258.115 0.008
202006 0.013 257.797 0.017
202009 0.011 260.280 0.014
202012 0.007 260.474 0.009
202103 0.023 264.877 0.029
202106 0.000 271.696 0.000
202109 0.062 274.310 0.075
202112 0.074 278.802 0.088
202203 0.080 287.504 0.092
202206 0.051 296.311 0.057
202209 0.059 296.808 0.066
202212 0.062 296.797 0.069
202303 0.111 301.836 0.121
202306 0.122 305.109 0.132
202309 0.056 307.789 0.060
202312 0.048 306.746 0.052
202403 0.037 312.332 0.039
202406 0.055 314.175 0.058
202409 0.065 315.301 0.068
202412 0.034 315.605 0.036
202503 0.049 319.799 0.051
202506 0.042 322.561 0.043
202509 0.038 324.800 0.039
202512 0.030 324.054 0.031
202603 0.024 330.213 0.024

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

What does a Cyclically Adjusted PS Ratio of 0.00 mean?
Dalrada Technology Group (DHTI) has a Cyclically Adjusted PS Ratio of 0.00 as of Jun. 24, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dalrada Technology Group and its competitors. Over the past decade, Dalrada Technology Group's Cyclically Adjusted PS Ratio has ranged from 0.01 to 0.03. According to the industry distribution chart, Dalrada Technology Group ranks #999999 out of 358 companies in the Healthcare Providers & Services industry.
Is Dalrada Technology Group's Cyclically Adjusted PS Ratio too high?
Dalrada Technology Group's current Cyclically Adjusted PS Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.03. Based on the distribution chart, Dalrada Technology Group ranks #999999 out of 358 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Dalrada Technology Group's Cyclically Adjusted PS Ratio compare to PMHS and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Dalrada Technology Group ranks #999999 out of 358 companies for Cyclically Adjusted PS Ratio. This places Dalrada Technology Group in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.16. Historically, Dalrada Technology Group's own Cyclically Adjusted PS Ratio has ranged from 0.01 to 0.03 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.16, based on 358 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dalrada Technology Group and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dalrada Technology Group's current Cyclically Adjusted PS Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dalrada Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Dalrada Technology Group (DHTI) is currently considered Possible Value Trap. The stock's GF Value™ is $0.05, compared to a current price of $0.02 — trading 52.6% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Dalrada Technology Group (DHTI), the current Cyclically Adjusted PS Ratio is 0.00 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dalrada Technology Group Business Description

Address 600 La Terraza Boulevard, Escondido, CA, USA, 92025
Dalrada Technology Group Inc is a United States-based company engaged in providing commercial and home heat pumps, building advanced physical deposition solutions for semiconductor manufacturers and clean energy applications, and driving enhanced healthcare initiatives through its subsidiaries like specialty pharmacy. Its business segments include: Climate Technology; Deposition Technology; and Genefic Healthcare.